À propos de ce podcast
Get answers in 25 minutes or less from world-class experts and earn CME/CE credit with CME in Minutes: Education in Oncology & Hematology by Answers in CME. Benefit from digests of latest advancements, thoughtful case studies, and nuanced perspectives. Inspiring and engaging programs designed for oncologists and hematologists to cover the diagnosis, staging, treatment, follow-up, and clinical management of tumors and hematological malignancies. Earning your CME/CE credits has never been faster…
164 épisodes · Levenswetenschappen
CME in Minutes: Education in Oncology & Hematology
À propos de ce podcast
Get answers in 25 minutes or less from world-class experts and earn CME/CE credit with CME in Minutes: Education in Oncology & Hematology by Answers in CME. Benefit from digests of latest advancements, thoughtful case studies, and nuanced perspectives. Inspiring and engaging programs designed for oncologists and hematologists to cover the diagnosis, staging, treatment, follow-up, and clinical management of tumors and hematological malignancies. Earning your CME/CE credits has never been faster…
Épisodes récents
- ADCs in Gynecologic Cancer Care: Enhancing the Patient’s Treatment Journey Through Optimal Adverse Event Management2 oct. · 25 min
- Adding Multi-Cancer Early Detection to the Primary Care Toolbox: Strategies for Everyday Practice28 sept. · 13 min
- Getting to the Heart of Prostate Cancer: Identifying and Managing Cardiovascular Risk in Patients Receiving Androgen-Deprivation Therapy22 sept. · 1 h 03 min
- Targeting TROP2 in Oncology: Pan-Tumor Insights and the Next Wave of ADC Innovation18 sept. · 13 min
- Sustaining Long-Term Care With ALK TKIs in Metastatic NSCLC: Best Practices for Adverse Event Management17 sept. · 20 min
- Case-Based Guidance on Tailoring Treatment Selection for Menopause-Related VMS7 sept. · 20 min
- Going Beyond the Guidelines: Incorporating Patient and Disease Factors to Optimize First-Line Treatment Strategies in LA/mUC1 sept. · 25 min
- Evolving Insights Into EZH 1/2 Inhibition in B- and T-Cell Lymphoma: Expert Perspectives on Latest Advancements28 août · 21 min
- Answering Clinician Questions About Anemia in Lower-Risk Myelodysplastic Syndromes: Community-Based Strategies to Enhance Long-Term Efficacy27 août · 20 min
- Redefining What’s Possible in mTNBC: The Expanding Frontier of TROP2-Directed ADCs17 août · 15 min
podlinkr.com/fr/cme-in-minutes-education-in-oncology-and-hematol
Pour une affiche ou une diapo.